Cancer Anorexia-Cachexia Syndrome Global Clinical Trials Review, H2, 2016

Products Id :- GDHC3735CTIDB
|
Pages: 92
|
August 2016
|
Region: Global
|

Request for Sample Report

Request A Quote

Executive Summary

Summary

GlobalData's clinical trial report, "Cancer Anorexia-Cachexia Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Cancer Anorexia-Cachexia Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Anorexia-Cachexia Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Cancer Anorexia-Cachexia Syndrome to Oncology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Cancer Anorexia-Cachexia Syndrome to Oncology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials 28

Prominent Drugs 30

Clinical Trial Profile Snapshots 31

Appendix 89

Abbreviations 89

Definitions 89

Research Methodology 90

Secondary Research 90

About GlobalData 91

Disclaimer 91

Source 92

List of Figures

Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14

Proportion of Cancer Anorexia-Cachexia Syndrome to Oncology Clinical Trials, G7 Countries (%), 2016* 15

Cancer Anorexia-Cachexia Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16

Cancer Anorexia-Cachexia Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17

Proportion of Cancer Anorexia-Cachexia Syndrome to Oncology Clinical Trials, E7 Countries (%), 2016* 18

Cancer Anorexia-Cachexia Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19

Cancer Anorexia-Cachexia Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20

Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21

Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22

Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25

Cancer Anorexia-Cachexia Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30

GlobalData Methodology 90

List of Tables

Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials by Region, 2016* 6

Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8

Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2016* 12

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14

Proportion of Cancer Anorexia-Cachexia Syndrome to Oncology Clinical Trials, G7 Countries (%), 2016* 15

Cancer Anorexia-Cachexia Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16

Cancer Anorexia-Cachexia Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17

Proportion of Cancer Anorexia-Cachexia Syndrome to Oncology Clinical Trials, E7 Countries (%), 2016* 18

Cancer Anorexia-Cachexia Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19

Cancer Anorexia-Cachexia Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20

Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials by Phase, 2016* 21

Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22

Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25

Cancer Anorexia-Cachexia Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29

Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Helsinn Holding S.A.

GTx, Inc.

Medpace Holdings, Inc.

Novartis AG

Tsumura & co.

Ohr Pharmaceutical Inc.

Merck & Co., Inc.

Endo International Plc

Ark Therapeutics Limited

Aeterna Zentaris Inc.

Cancer Anorexia-Cachexia Syndrome Global Clinical Trials Review, H2, 2016

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

Wish to Know more

download

For Further Enquiry

apply for job

Know how We Roll

Engage with Us